4/A//SEC Filing
Sims Andrew John Hugh MacIntyre 4/A
Accession 0001193125-25-230288
CIK 0001095981other
Filed
Oct 2, 8:00 PM ET
Accepted
Oct 3, 4:30 PM ET
Size
8.0 KB
Accession
0001193125-25-230288
Insider Transaction Report
Form 4/AAmended
Sims Andrew John Hugh MacIntyre
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-08-13+1,379,636→ 1,379,636 totalExercise: $0.57Exp: 2035-08-12→ Common Stock (1,379,636 underlying) - Award
Restricted Stock Units
2025-08-13+459,878→ 459,878 total→ Common Stock (459,878 underlying)
Footnotes (2)
- [F1]The options vest over four years in equal 1/48th increments on each monthly anniversary of the issuance.
- [F2]This amendment is being filed to correct a Form 4 filed on August 15, 2025, which inadvertently disclosed the incorrect vesting terms of the Restricted Stock Units ("RSUs"). The RSUs awarded on August 13, 2025 vest over twelve quarters, vesting in substantially equal 1/12th increments beginning with the quarter ended September 30, 2025. The RSUs convert into shares of Common Stock upon vesting on a one for one basis.
Documents
Issuer
PLUS THERAPEUTICS, INC.
CIK 0001095981
Entity typeother
Related Parties
1- filerCIK 0001802687
Filing Metadata
- Form type
- 4/A
- Filed
- Oct 2, 8:00 PM ET
- Accepted
- Oct 3, 4:30 PM ET
- Size
- 8.0 KB